This year we are excited to announce a Consortium event on Friday May 3rd before the main ESTRO24 program in Glasgow.

The event will be hosted in the Voco Grand Central Glasgow, 99 Gordon St, Glasgow G1 3SF.

The agenda is split into two parts:

– Morning session (9:00-12:00) will be a closed Consortium members-only session including a workshop around current and future practice, research opportunities and an Elekta and Phillips update. 

– Afternoon session (13:00-17:00) will be open to Consortium members, invited guests and other ESTRO attendees (upon invitation only) and will focus on Consortium activities, generation of clinical evidence and best practice sharing. There will be presentations from various member sites as well as sessions exploring the clinical evidence generated by our research programs MOMENTUM and the Hypothesis Testing Program. 

Time	Topic	Speaker
13:00	Welcome	Alison Tree, MD, Chair of the MR-Linac Consortium Gustaf Salford, CEO, Elekta
13:10	State of the evidence: pancreas, kidney and prostate	Anna Bruynzeel, MD, Amsterdam UMC, The Netherlands
13:40	New indications and treatment strategies with CMM	Prof. Filippo Alongi, MD, IRCCS Sacro Cuore Don Calabria Cancer Care Center of Negrar, Italy
14:20	Innovations Within the Standard of Care	Inma Navarro Domènech, MD, Hospital Universitario La Paz, Spain, Prof. Michael J. Zelefsky, MD, NYU Langone Health, USA, Jeremy de Leon, MD, GenesisCare, St Vincent’s Sydney, Australia
15:10	Coffee break
15:30	Reinforcing the MRgRT evidence base: Hypothesis Testing Program updates	Alison Tree, MD, The Royal Marsden NHS Foundation Trust and Institute of Cancer Research, UK, Prof. Cihan Gani, MD, University of Tubingen, Germany
15:45	Key learnings from the MOMENTUM study	Prof. dr. Lenny Verkooijen, the Netherlands Cancer Institute, The Netherlands, Lois Daamen, MD, PhD, UMC Utrecht, The Netherlands
16:00	Panel discussion
17:00	Close

We are looking forward to seeing you at this next event!